Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Terbinafine for Toenail Onychomycosis
NCT00443820Phase 3Completed
- Sponsor
- Novartis
- Start
- Dec 2006
- Primary completion
- Jun 2008
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Phase 3, randomised, double-blind trial of Terbinafine in onychomycosis (4 arms), sponsored by Novartis. Primary endpoint: Percentage of Participants With Complete Cure at 52 weeks. Started Dec 2006; status: completed.
02
Drugs
Terbinafine
03
Conditions
onychomycosis
Beyond the preview
Go deeper on NCT00443820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00443820.